Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry

•Direct infusion mass spectrometry allows a comprehensive brain metabolomic analysis.•The APP/PS1 mice exhibited an abnormal neurochemical profile compared to controls.•These failures affected hippocampus, cortex, cerebellum and olfactory bulbs.•Pathway analysis revealed multiple significant impairm...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical and biomedical analysis Vol. 102; pp. 425 - 435
Main Authors González-Domínguez, Raúl, García-Barrera, Tamara, Vitorica, Javier, Gómez-Ariza, José Luis
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 05.01.2015
Subjects
Online AccessGet full text
ISSN0731-7085
1873-264X
1873-264X
DOI10.1016/j.jpba.2014.10.009

Cover

Loading…
Abstract •Direct infusion mass spectrometry allows a comprehensive brain metabolomic analysis.•The APP/PS1 mice exhibited an abnormal neurochemical profile compared to controls.•These failures affected hippocampus, cortex, cerebellum and olfactory bulbs.•Pathway analysis revealed multiple significant impairments in brain metabolism. The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease.
AbstractList The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease.The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease.
The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease.
•Direct infusion mass spectrometry allows a comprehensive brain metabolomic analysis.•The APP/PS1 mice exhibited an abnormal neurochemical profile compared to controls.•These failures affected hippocampus, cortex, cerebellum and olfactory bulbs.•Pathway analysis revealed multiple significant impairments in brain metabolism. The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease.
Author Gómez-Ariza, José Luis
González-Domínguez, Raúl
García-Barrera, Tamara
Vitorica, Javier
Author_xml – sequence: 1
  givenname: Raúl
  surname: González-Domínguez
  fullname: González-Domínguez, Raúl
  organization: Department of Chemistry and CC.MM, Faculty of Experimental Sciences, University of Huelva, Campus de El Carmen, 21007 Huelva, Spain
– sequence: 2
  givenname: Tamara
  surname: García-Barrera
  fullname: García-Barrera, Tamara
  email: tamara@dqcm.uhu.es
  organization: Department of Chemistry and CC.MM, Faculty of Experimental Sciences, University of Huelva, Campus de El Carmen, 21007 Huelva, Spain
– sequence: 3
  givenname: Javier
  surname: Vitorica
  fullname: Vitorica, Javier
  organization: Department Bioquímica, Bromatologia, Toxicología y Medicina Legal, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain
– sequence: 4
  givenname: José Luis
  surname: Gómez-Ariza
  fullname: Gómez-Ariza, José Luis
  email: ariza@uhu.es
  organization: Department of Chemistry and CC.MM, Faculty of Experimental Sciences, University of Huelva, Campus de El Carmen, 21007 Huelva, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25459942$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1uEzEUhS1URNPCC7BA3sEmqe2x50diE1X8SUVEAiR2lu25Th3NjIOvUym8BK-Mh7QbFhUrXx-d7yzOuSBnU5yAkJecrTjj9dVutdtbsxKMyyKsGOuekAVvm2opavnjjCxYU_Flw1p1Ti4Qd4wxxTv5jJwLJVXXSbEgvz9DNjYOcQyOoksAU5i2NHqaYBviZAZqkwkTNUOGZHKRkJZvvgW63myuNl85zclMuC2go2PsYZjp9fDrFsII6TXSPiAYBGqP5UzgcgnwByxRdDSIFPdFS3GEnI7PyVNvBoQX9-8l-f7-3bfrj8ubLx8-Xa9vlk52XV620ForasWs90apxjIFsmZVI3vT8c743tbCNUKxyjPjufU1yMoIqJh3Tc2rS_LmlLtP8ecBMOsxoINhMBPEA2pel7S2FZz9h1UJWTV12xXrq3vrwY7Q630Ko0lH_dB3MbQng0sRMYHXLuS_rZYSw6A50_O0eqfnafU87ayVaQsq_kEf0h-F3p4gKF3eBUgaXYDJwWkI3cfwGP4HQ7y-sg
CitedBy_id crossref_primary_10_1016_j_bbih_2023_100599
crossref_primary_10_1016_j_talanta_2022_124046
crossref_primary_10_1016_j_jprot_2016_07_032
crossref_primary_10_1371_journal_pone_0155694
crossref_primary_10_1021_acs_jproteome_8b00847
crossref_primary_10_1371_journal_pone_0174763
crossref_primary_10_1007_s12035_019_1586_2
crossref_primary_10_1016_j_neuint_2015_11_005
crossref_primary_10_1021_acs_jproteome_0c00255
crossref_primary_10_1038_s41598_020_63483_w
crossref_primary_10_1016_j_heliyon_2024_e39104
crossref_primary_10_1111_nyas_13385
crossref_primary_10_1021_acs_analchem_2c00676
crossref_primary_10_1016_j_bbadis_2023_166910
crossref_primary_10_2174_1567205017666201109091759
crossref_primary_10_1186_s13041_020_0565_x
crossref_primary_10_1021_acs_jproteome_0c01050
crossref_primary_10_3389_fphar_2021_788312
crossref_primary_10_3390_biomedicines9030298
crossref_primary_10_1016_j_nut_2021_111499
crossref_primary_10_4155_bio_2016_0202
crossref_primary_10_1016_j_bbadis_2017_10_028
crossref_primary_10_1039_C8RA01574K
crossref_primary_10_3389_fnut_2021_769218
crossref_primary_10_1016_j_jpba_2015_01_025
crossref_primary_10_3389_fneur_2017_00719
crossref_primary_10_1080_14789450_2021_1948330
crossref_primary_10_1172_jci_insight_150099
crossref_primary_10_3389_fnagi_2022_1023493
crossref_primary_10_1016_j_exger_2016_12_019
crossref_primary_10_1021_acs_analchem_5b02871
crossref_primary_10_1038_s41598_020_71510_z
crossref_primary_10_1124_pharmrev_122_000679
crossref_primary_10_1016_j_biochi_2015_01_005
crossref_primary_10_1186_s13195_024_01549_x
crossref_primary_10_1002_jnr_24750
crossref_primary_10_1016_j_jchromb_2017_02_008
crossref_primary_10_1016_j_brainres_2021_147481
crossref_primary_10_1038_s41598_023_30892_6
crossref_primary_10_1093_braincomms_fcab139
crossref_primary_10_1016_j_arr_2023_101987
crossref_primary_10_1039_C4MB00747F
crossref_primary_10_1016_j_jgr_2015_04_006
crossref_primary_10_1016_j_jchromb_2016_09_023
crossref_primary_10_3390_ijms24054960
crossref_primary_10_1038_s41598_020_68739_z
crossref_primary_10_1002_ctd2_287
crossref_primary_10_3390_nu14040735
crossref_primary_10_1038_s41598_020_70703_w
crossref_primary_10_1007_s12035_023_03533_2
crossref_primary_10_3233_JAD_170880
crossref_primary_10_3389_fphar_2023_1338804
crossref_primary_10_1016_j_bbrc_2017_09_164
crossref_primary_10_1038_s41598_024_51463_3
crossref_primary_10_1051_ocl_2018027
crossref_primary_10_1016_j_neulet_2020_135401
crossref_primary_10_4155_bio_2018_0135
crossref_primary_10_1007_s41664_017_0018_4
crossref_primary_10_1016_j_plipres_2023_101223
crossref_primary_10_14336_AD_2020_0217
crossref_primary_10_1016_j_jpba_2016_07_008
crossref_primary_10_1186_s13195_023_01162_4
crossref_primary_10_1016_j_pnpbp_2023_110848
crossref_primary_10_3390_ijms231911560
crossref_primary_10_1007_s11306_015_0773_z
crossref_primary_10_1002_elps_201400544
crossref_primary_10_3389_fnmol_2021_665788
Cites_doi 10.1016/j.plipres.2011.06.001
10.1371/journal.pone.0032737
10.1016/j.nbd.2012.09.003
10.3233/JAD-2010-100630
10.4061/2011/517160
10.1111/j.1750-3639.2003.tb00475.x
10.1039/b604498k
10.1016/j.bbr.2010.03.026
10.1194/jlr.R300005-JLR200
10.1016/j.brainres.2004.02.079
10.1371/journal.pone.0031501
10.1016/j.molmed.2007.12.001
10.1016/S0197-4580(98)00083-9
10.1007/BF03159937
10.1046/j.1471-4159.1997.68052061.x
10.1074/jbc.M111.274142
10.1186/1471-2164-7-142
10.1007/s12017-012-8173-2
10.1021/pr300666p
10.3233/JAD-130023
10.1007/s11306-012-0449-x
10.3233/JAD-131463
10.1016/j.aca.2004.07.065
10.1016/S0021-9673(02)01838-1
10.1016/0304-3940(95)12256-7
10.1002/jnr.22479
10.1016/j.jprot.2014.01.014
10.1111/j.1750-3639.2007.00112.x
10.2478/s11696-012-0184-9
10.1016/j.bbagen.2010.06.002
10.1093/hmg/ddh019
10.1016/j.brainresbull.2011.11.017
10.1002/mas.20108
10.1007/s11064-008-9673-1
10.1016/j.talanta.2013.09.019
10.1007/BF01705539
10.1046/j.1471-4159.2001.00332.x
10.1002/elps.201100139
10.1007/s11064-004-6871-3
10.1093/bioinformatics/btq418
10.1111/j.1742-4658.2005.04911.x
10.1586/14737159.4.2.189
10.1007/s11306-013-0516-y
10.1016/j.brainres.2009.07.066
10.1016/j.neuint.2010.04.001
10.1194/jlr.D001750
10.1016/j.neurobiolaging.2007.03.002
10.1097/NEN.0b013e31826be03c
10.3390/ijms141021021
10.1016/j.bbr.2012.07.016
10.1016/j.celrep.2012.05.001
10.1007/s00216-013-6825-1
10.1007/s00401-011-0836-9
10.1002/ana.410210403
10.1039/c0an00265h
10.1016/j.ijms.2011.10.002
10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q
10.1007/s11306-009-0187-x
10.1007/s11306-013-0610-1
10.1002/nbm.1712
10.1046/j.1471-4159.1998.71052034.x
10.1038/srep02364
10.1016/j.jpba.2014.05.023
10.1002/mas.10061
10.1007/s00726-006-0409-8
10.1016/j.neurobiolaging.2004.02.016
10.2174/1567205011310040005
10.1016/0304-3940(95)12058-C
ContentType Journal Article
Copyright 2014 Elsevier B.V.
Copyright © 2014 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2014 Elsevier B.V.
– notice: Copyright © 2014 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7QO
7U7
8FD
C1K
FR3
P64
DOI 10.1016/j.jpba.2014.10.009
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Biotechnology Research Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Toxicology Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE - Academic
Engineering Research Database
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-264X
EndPage 435
ExternalDocumentID 25459942
10_1016_j_jpba_2014_10_009
S0731708514005007
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AATCM
AAXUO
ABFRF
ABJNI
ABMAC
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADECG
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
M34
M36
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
RIG
RNS
ROL
RPZ
SCC
SCH
SDF
SDG
SDP
SES
SPC
SPCBC
SSK
SSP
SSZ
T5K
TEORI
YK3
~G-
29L
53G
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABFNM
ABWVN
ABXDB
ACNNM
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AHHHB
AIGII
AIIUN
AJQLL
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
BNPGV
CITATION
FEDTE
FGOYB
G-2
HMT
HMU
HVGLF
HZ~
R2-
SCB
SEW
SPT
SSH
WUQ
XPP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFKBS
7QO
7U7
8FD
C1K
FR3
P64
ID FETCH-LOGICAL-c499t-8e8bb2650bffa557b05e460374da919afdb62c72503f0af1bf6e43a2e30fc7613
IEDL.DBID .~1
ISSN 0731-7085
1873-264X
IngestDate Tue Aug 05 10:35:27 EDT 2025
Sun Aug 24 03:01:39 EDT 2025
Thu Apr 03 07:00:49 EDT 2025
Thu Apr 24 22:52:36 EDT 2025
Tue Jul 01 01:17:37 EDT 2025
Fri Feb 23 02:34:15 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Metabolomics
Brain regions
Direct infusion mass spectrometry
APP/PS1 mice
Alzheimer's disease
Language English
License Copyright © 2014 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c499t-8e8bb2650bffa557b05e460374da919afdb62c72503f0af1bf6e43a2e30fc7613
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://hdl.handle.net/10272/14594
PMID 25459942
PQID 1652437689
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_1660388210
proquest_miscellaneous_1652437689
pubmed_primary_25459942
crossref_citationtrail_10_1016_j_jpba_2014_10_009
crossref_primary_10_1016_j_jpba_2014_10_009
elsevier_sciencedirect_doi_10_1016_j_jpba_2014_10_009
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-01-05
PublicationDateYYYYMMDD 2015-01-05
PublicationDate_xml – month: 01
  year: 2015
  text: 2015-01-05
  day: 05
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of pharmaceutical and biomedical analysis
PublicationTitleAlternate J Pharm Biomed Anal
PublicationYear 2015
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Strott, Higashi (bib0285) 2003; 44
Lo, Callaerts-Vegh, Nunes, Rodrigues, D‘Hooge (bib0295) 2013; 50
Fabelo, Martín, Marín, Santpere, Aso, Ferrer, Díaz (bib0280) 2012; 71
Gonzalez-Dominguez, Garcia-Barrera, Gomez-Ariza (bib0165) 2014; 104
Perry, Yong, Bergeron, Hansen, Jones (bib0330) 1987; 21
Fonteh, Harrington, Tsai, Liao, Harrington (bib0305) 2007; 32
Lokhov, Kharybin, Archakov (bib0155) 2012; 309
Frisardi, Panza, Seripa, Farooqui, Farooqui (bib0185) 2011; 50
Gabbita, Lovell, Markesbery (bib0275) 1998; 71
Pulfer, Murphy (bib0125) 2003; 22
Cai, Yan, Li, Quazi, Zhao (bib0250) 2012; 14
Lokhov, Dashtiev, Moshkovskii, Archakov (bib0150) 2010; 6
Lyras, Cairns, Jenner, Jenner, Halliwell (bib0270) 1997; 68
Albasanz, Perez, Barrachina, Ferrer, Martín (bib0255) 2008; 18
Yang, He, Schulz (bib0230) 2005; 272
Lin, Kanawati, Liu, Witting, Li, Huang, Schmitt-Kopplin, Cai (bib0105) 2014; 118
Woo, Lee, Lee, Kim, Kim, Rhim, Choi, Kim, Lee, Choe (bib0060) 2010; 211
Axelsen, Murphy (bib0210) 2010; 51
Yao, Wengenack, Curran, Poduslo (bib0190) 2009; 34
Hu, Browne, Liu, Angel, Ho, Chan (bib0080) 2012; 11
Lin, Yu, Yan, Hang, Zheng, Xing, Huang (bib0145) 2010; 135
Kou, Kovacs, Höftberger, Kulik, Brodde, Forss-Petter, Hönigschnabl, Gleiss, Brügger, Wanders, Just, Budka, Jungwirth, Fischer, Berger (bib0205) 2011; 122
Xia, Wishart (bib0140) 2010; 26
Yao, Hamilton, Cadenas, Brinton (bib0225) 2010; 1800
Sims, Powers, Sabina, Theibert (bib0245) 1998; 19
Cuadrado-Tejedor, Cabodevilla, Zamarbide, Gómez-Isla, Franco, Perez-Mediavilla (bib0235) 2013; 10
Filalia, Lalonde (bib0015) 2009; 1292
Yatin, Yatin, Varadarajan, Ain, Butterfield (bib0315) 2001; 63
Angulo, Casadó, Mallol, Canela, Viñals, Ferrer, Lluis, Franco (bib0260) 2003; 13
Vernez, Hopfgartner, Wenk, Krahenbuhl (bib0135) 2003; 984
Salek, Xia, Innes, Sweatman, Adalbert, Randle, McGowan, Emson, Griffin (bib0055) 2010; 56
Trushina, Nemutlu, Zhang, Christensen, Camp, Mesa, Siddiqui, Tamura, Sesaki, Wengenack, Dzeja, Poduslo (bib0085) 2012; 7
Ramalho, Viana, Low, Steer, Rodrigues (bib0290) 2008; 14
Walter, Korth, Hilgert, Hartmann, Weichel, Hilgert, Fassbender, Schmitt, Klein (bib0180) 2004; 25
van den Berg, Hoefsloot, Westerhuis, Smilde, van der Werf (bib0120) 2006; 7
Draper, Lloyd, Goodacre, Beckmann (bib0095) 2013; 9
Hansmannel, Sillaire, Kamboh, Lendon, Pasquier, Hannequin, Laumet, Mounier, Ayral, DeKosky, Hauw, Berr, Mann, Amouyel, Campion, Lambert (bib0325) 2010; 21
Wang, Xie, Yang, Yang, Xu (bib0130) 2004; 525
Lindon, Holmes, Nicholson (bib0020) 2004; 4
Chan, Oliveira, Cortes, Honig, Duff, Small, Wenk, Shui, Di Paolo (bib0200) 2012; 287
Malm, Koistinaho, Kanninen (bib0010) 2011; 2011
Samakashvili, Ibáñez, Simó, Gil-Bea, Winblad, Cedazo-Mínguez, Cifuentes (bib0310) 2011; 32
Makar, Cooper, Tofel-Grehl, Thaler, Blass (bib0220) 1995; 20
Storga, Vrecko, Birkmayer, Reibnegger (bib0300) 1996; 203
Graham, Holscher, McClean, Elliott, Green (bib0050) 2013; 9
Jankowsky, Fadale, Anderson, Xu, Gonzales, Jenkins, Copeland, Lee, Younkin, Wagner, Younkin, Borchelt (bib0110) 2004; 13
González-Domínguez, García-Barrera, Gómez-Ariza (bib0170) 2014; 98
Oberg, Spenger, Wang, Andersson, Westman, Skoglund, Sunnemark, Norinder, Klason, Wahlund, Lindberg (bib0025) 2008; 29
Dettmer, Aronov, Hammock (bib0070) 2007; 26
Piro, Benjamin, Duerr, Pi, Gonzales, Wood, Schwartz, Nomura, Samad (bib0075) 2012; 1
Gonzalez-Dominguez, Garcia-Barrera, Gomez-Ariza (bib0160) 2012; 66
Forster, James, Williams (bib0045) 2012; 25
Adams, Klaidman, Odunze, Shen, Miller (bib0340) 1991; 14
Sangster, Major, Plumb, Wilson, Wilson (bib0115) 2006; 131
Han, Holtzman (bib0195) 2001; 77
Chen, Cai, Shen, Wang, Teng, Zhang, Zang (bib0035) 2012; 235
Wang, Lian, Han, Wang, Kuo, Geng, Qiang, Sun, Wang (bib0090) 2014; 39
Xu, Zhan, Huang, Wang, Zhang, Lei (bib0030) 2010; 88
Hall, Roberson (bib0005) 2012; 88
Graham, Holscher, Green (bib0215) 2014; 10
Aoyama, Nakaki (bib0335) 2013; 14
Lalande, Halley, Balayssac, Gilard, Déjean, Martino, Francés, Lassalle, Malet-Martino (bib0065) 2014; 39
Czech, Berndt, Busch, Schmitz, Wiemer, Most, Hampel, Kastler, Senn (bib0265) 2012; 7
Lin, Liu, Kanawati, Liu, Dong, Li, Huang, Schmitt-Kopplin, Cai (bib0100) 2013; 405
Parnetti, Gaiti, Polidori, Brunetti, Palumbo, Chionne, Cadini, Cecchetti, Senin (bib0345) 2005; 199
Dedeoglu, Choi, Cormier, Kowall, Jenkins (bib0040) 2004; 1012
Farooqui, Ong, Horrocks (bib0175) 2004; 29
Inoue, Tsutsui, Akatsu, Hashizume, Matsukawa, Yamamoto, Toyo’oka (bib0320) 2013; 3
Fabelo (10.1016/j.jpba.2014.10.009_bib0280) 2012; 71
Wang (10.1016/j.jpba.2014.10.009_bib0090) 2014; 39
Lin (10.1016/j.jpba.2014.10.009_bib0145) 2010; 135
Makar (10.1016/j.jpba.2014.10.009_bib0220) 1995; 20
Sangster (10.1016/j.jpba.2014.10.009_bib0115) 2006; 131
Ramalho (10.1016/j.jpba.2014.10.009_bib0290) 2008; 14
Lin (10.1016/j.jpba.2014.10.009_bib0105) 2014; 118
Gonzalez-Dominguez (10.1016/j.jpba.2014.10.009_bib0165) 2014; 104
Xia (10.1016/j.jpba.2014.10.009_bib0140) 2010; 26
Lo (10.1016/j.jpba.2014.10.009_bib0295) 2013; 50
Forster (10.1016/j.jpba.2014.10.009_bib0045) 2012; 25
Yao (10.1016/j.jpba.2014.10.009_bib0225) 2010; 1800
Lokhov (10.1016/j.jpba.2014.10.009_bib0155) 2012; 309
Gonzalez-Dominguez (10.1016/j.jpba.2014.10.009_bib0160) 2012; 66
Kou (10.1016/j.jpba.2014.10.009_bib0205) 2011; 122
Malm (10.1016/j.jpba.2014.10.009_bib0010) 2011; 2011
Sims (10.1016/j.jpba.2014.10.009_bib0245) 1998; 19
Han (10.1016/j.jpba.2014.10.009_bib0195) 2001; 77
Salek (10.1016/j.jpba.2014.10.009_bib0055) 2010; 56
Parnetti (10.1016/j.jpba.2014.10.009_bib0345) 2005; 199
Aoyama (10.1016/j.jpba.2014.10.009_bib0335) 2013; 14
Trushina (10.1016/j.jpba.2014.10.009_bib0085) 2012; 7
Filalia (10.1016/j.jpba.2014.10.009_bib0015) 2009; 1292
González-Domínguez (10.1016/j.jpba.2014.10.009_bib0170) 2014; 98
Chen (10.1016/j.jpba.2014.10.009_bib0035) 2012; 235
Wang (10.1016/j.jpba.2014.10.009_bib0130) 2004; 525
Gabbita (10.1016/j.jpba.2014.10.009_bib0275) 1998; 71
Hu (10.1016/j.jpba.2014.10.009_bib0080) 2012; 11
Angulo (10.1016/j.jpba.2014.10.009_bib0260) 2003; 13
Perry (10.1016/j.jpba.2014.10.009_bib0330) 1987; 21
Xu (10.1016/j.jpba.2014.10.009_bib0030) 2010; 88
Inoue (10.1016/j.jpba.2014.10.009_bib0320) 2013; 3
Woo (10.1016/j.jpba.2014.10.009_bib0060) 2010; 211
Albasanz (10.1016/j.jpba.2014.10.009_bib0255) 2008; 18
Lin (10.1016/j.jpba.2014.10.009_bib0100) 2013; 405
Cai (10.1016/j.jpba.2014.10.009_bib0250) 2012; 14
Hall (10.1016/j.jpba.2014.10.009_bib0005) 2012; 88
Oberg (10.1016/j.jpba.2014.10.009_bib0025) 2008; 29
Chan (10.1016/j.jpba.2014.10.009_bib0200) 2012; 287
Fonteh (10.1016/j.jpba.2014.10.009_bib0305) 2007; 32
Yatin (10.1016/j.jpba.2014.10.009_bib0315) 2001; 63
Walter (10.1016/j.jpba.2014.10.009_bib0180) 2004; 25
Lyras (10.1016/j.jpba.2014.10.009_bib0270) 1997; 68
Dedeoglu (10.1016/j.jpba.2014.10.009_bib0040) 2004; 1012
Hansmannel (10.1016/j.jpba.2014.10.009_bib0325) 2010; 21
van den Berg (10.1016/j.jpba.2014.10.009_bib0120) 2006; 7
Draper (10.1016/j.jpba.2014.10.009_bib0095) 2013; 9
Yao (10.1016/j.jpba.2014.10.009_bib0190) 2009; 34
Graham (10.1016/j.jpba.2014.10.009_bib0050) 2013; 9
Cuadrado-Tejedor (10.1016/j.jpba.2014.10.009_bib0235) 2013; 10
Adams (10.1016/j.jpba.2014.10.009_bib0340) 1991; 14
Lalande (10.1016/j.jpba.2014.10.009_bib0065) 2014; 39
Frisardi (10.1016/j.jpba.2014.10.009_bib0185) 2011; 50
Samakashvili (10.1016/j.jpba.2014.10.009_bib0310) 2011; 32
Axelsen (10.1016/j.jpba.2014.10.009_bib0210) 2010; 51
Graham (10.1016/j.jpba.2014.10.009_bib0215) 2014; 10
Piro (10.1016/j.jpba.2014.10.009_bib0075) 2012; 1
Czech (10.1016/j.jpba.2014.10.009_bib0265) 2012; 7
Vernez (10.1016/j.jpba.2014.10.009_bib0135) 2003; 984
Storga (10.1016/j.jpba.2014.10.009_bib0300) 1996; 203
Jankowsky (10.1016/j.jpba.2014.10.009_bib0110) 2004; 13
Yang (10.1016/j.jpba.2014.10.009_bib0230) 2005; 272
Strott (10.1016/j.jpba.2014.10.009_bib0285) 2003; 44
Lokhov (10.1016/j.jpba.2014.10.009_bib0150) 2010; 6
Dettmer (10.1016/j.jpba.2014.10.009_bib0070) 2007; 26
Pulfer (10.1016/j.jpba.2014.10.009_bib0125) 2003; 22
Lindon (10.1016/j.jpba.2014.10.009_bib0020) 2004; 4
Farooqui (10.1016/j.jpba.2014.10.009_bib0175) 2004; 29
References_xml – volume: 11
  start-page: 5903
  year: 2012
  end-page: 5913
  ident: bib0080
  article-title: Metabonomic profiling of TASTPM transgenic alzheimer's disease mouse model
  publication-title: J. Proteome Res.
– volume: 13
  start-page: 159
  year: 2004
  end-page: 170
  ident: bib0110
  article-title: Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific g secretase
  publication-title: Hum. Mol. Genet.
– volume: 1800
  start-page: 1121
  year: 2010
  end-page: 1126
  ident: bib0225
  article-title: Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence
  publication-title: Biochim. Biophys. Acta
– volume: 32
  start-page: 213
  year: 2007
  end-page: 224
  ident: bib0305
  article-title: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects
  publication-title: Amino Acids
– volume: 1012
  start-page: 60
  year: 2004
  end-page: 65
  ident: bib0040
  article-title: Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile
  publication-title: Brain Res.
– volume: 39
  start-page: 121
  year: 2014
  end-page: 143
  ident: bib0065
  article-title: H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages
  publication-title: J. Alzheimers Dis.
– volume: 211
  start-page: 125
  year: 2010
  end-page: 131
  ident: bib0060
  article-title: Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP–PS1 by
  publication-title: Behav. Brain Res.
– volume: 287
  start-page: 2678
  year: 2012
  end-page: 2688
  ident: bib0200
  article-title: Comparative lipidomic analysis of mouse and human brain with Alzheimer disease
  publication-title: J. Biol. Chem.
– volume: 6
  start-page: 156
  year: 2010
  end-page: 163
  ident: bib0150
  article-title: Metabolite profiling of blood plasma of patients with prostate cancer
  publication-title: Metabolomics
– volume: 18
  start-page: 211
  year: 2008
  end-page: 219
  ident: bib0255
  article-title: Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease
  publication-title: Brain Pathol.
– volume: 13
  start-page: 440
  year: 2003
  end-page: 451
  ident: bib0260
  article-title: A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer's disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation
  publication-title: Brain Pathol.
– volume: 2011
  start-page: 517160
  year: 2011
  ident: bib0010
  article-title: Utilization of APPswe/PS1dE9 transgenic mice in research of Alzheimer's disease: focus on gene therapy and cell-based therapy applications
  publication-title: Int. J. Alzheimers Dis.
– volume: 118
  start-page: 45
  year: 2014
  end-page: 53
  ident: bib0105
  article-title: Ultra high resolution mass spectrometry-based metabolic characterization reveals cerebellum as a disturbed region in two animal models
  publication-title: Talanta
– volume: 26
  start-page: 51
  year: 2007
  end-page: 78
  ident: bib0070
  article-title: Mass spectrometry-based metabolomics
  publication-title: Mass Spectrom. Rev.
– volume: 25
  start-page: 1299
  year: 2004
  end-page: 1303
  ident: bib0180
  article-title: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients
  publication-title: Neurobiol. Aging
– volume: 272
  start-page: 4874
  year: 2005
  end-page: 4883
  ident: bib0230
  article-title: 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease
  publication-title: FEBS J.
– volume: 26
  start-page: 2342
  year: 2010
  end-page: 2344
  ident: bib0140
  article-title: MetPA: a web-based metabolomics tool for pathway analysis and visualization
  publication-title: Bioinformatics
– volume: 77
  start-page: 1168
  year: 2001
  end-page: 1180
  ident: bib0195
  article-title: McKeel Jr DW. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry
  publication-title: J. Neurochem.
– volume: 984
  start-page: 203
  year: 2003
  end-page: 213
  ident: bib0135
  article-title: Determination of carnitine and acylcarnitines in urine by high-performance liquid chromatography–electrospray ionization ion trap tandem mass spectrometry
  publication-title: J. Chromatogr. A
– volume: 405
  start-page: 5105
  year: 2013
  end-page: 5117
  ident: bib0100
  article-title: Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer's disease in CRND8 mice
  publication-title: Anal. Bioanal. Chem.
– volume: 309
  start-page: 200
  year: 2012
  end-page: 205
  ident: bib0155
  article-title: Diagnosis of lung cancer based on direct-infusion electrospray mass spectrometry of blood plasma metabolites
  publication-title: Int. J. Mass Spectrom.
– volume: 34
  start-page: 102
  year: 2009
  end-page: 108
  ident: bib0190
  article-title: Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice
  publication-title: Neurochem. Res.
– volume: 21
  start-page: 1013
  year: 2010
  end-page: 1021
  ident: bib0325
  article-title: Is the urea cycle involved in Alzheimer's disease
  publication-title: J. Alzheimers Dis.
– volume: 56
  start-page: 937
  year: 2010
  end-page: 943
  ident: bib0055
  article-title: A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease
  publication-title: Neurochem. Int.
– volume: 3
  start-page: 2364
  year: 2013
  ident: bib0320
  article-title: Metabolic profiling of Alzheimer's disease brains
  publication-title: Sci. Rep.
– volume: 39
  start-page: 841
  year: 2014
  end-page: 848
  ident: bib0090
  article-title: Age-related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: a spontaneous Alzheimer's disease mouse model
  publication-title: J. Alzheimers Dis.
– volume: 1
  start-page: 617
  year: 2012
  end-page: 623
  ident: bib0075
  article-title: A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease
  publication-title: Cell Rep.
– volume: 7
  start-page: 142
  year: 2006
  ident: bib0120
  article-title: Centering, scaling, and transformations: improving the biological information content of metabolomics data
  publication-title: BMC Genomics
– volume: 20
  start-page: 705
  year: 1995
  end-page: 711
  ident: bib0220
  article-title: Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain
  publication-title: Neurochem. Res.
– volume: 135
  start-page: 2970
  year: 2010
  end-page: 2978
  ident: bib0145
  article-title: Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer
  publication-title: Analyst
– volume: 14
  start-page: 21021
  year: 2013
  end-page: 21044
  ident: bib0335
  article-title: Impaired glutathione synthesis in neurodegeneration
  publication-title: Int. J. Mol. Sci.
– volume: 235
  start-page: 1
  year: 2012
  end-page: 6
  ident: bib0035
  article-title: Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice
  publication-title: Behav. Brain Res.
– volume: 14
  start-page: 54
  year: 2008
  end-page: 62
  ident: bib0290
  article-title: Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease
  publication-title: Trends Mol. Med.
– volume: 50
  start-page: 313
  year: 2011
  end-page: 330
  ident: bib0185
  article-title: Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology
  publication-title: Prog. Lipid Res.
– volume: 21
  start-page: 331
  year: 1987
  end-page: 336
  ident: bib0330
  article-title: Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease
  publication-title: Ann. Neurol.
– volume: 4
  start-page: 189
  year: 2004
  end-page: 199
  ident: bib0020
  article-title: Metabonomics and its role in drug development and disease diagnosis
  publication-title: Expert Rev. Mol. Diagn.
– volume: 29
  start-page: 1961
  year: 2004
  end-page: 1977
  ident: bib0175
  article-title: Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A
  publication-title: Neurochem. Res.
– volume: 88
  start-page: 3
  year: 2012
  end-page: 12
  ident: bib0005
  article-title: Mouse models of Alzheimer's disease
  publication-title: Brain Res. Bull.
– volume: 88
  start-page: 3155
  year: 2010
  end-page: 3160
  ident: bib0030
  article-title: Reduction of hippocampal N-acetyl aspartate level in aged APPSwe/PS1dE9 transgenic mice is associated with degeneration of CA3 pyramidal neurons
  publication-title: J. Neurosci. Res.
– volume: 50
  start-page: 21
  year: 2013
  end-page: 29
  ident: bib0295
  article-title: Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice
  publication-title: Neurobiol. Dis.
– volume: 122
  start-page: 271
  year: 2011
  end-page: 283
  ident: bib0205
  article-title: Peroxisomal alterations in Alzheimer's disease
  publication-title: Acta Neuropathol.
– volume: 19
  start-page: 385
  year: 1998
  end-page: 391
  ident: bib0245
  article-title: Elevated adenosine monophosphate deaminase activity in Alzheimer's disease brain
  publication-title: Neurobiol. Aging
– volume: 22
  start-page: 332
  year: 2003
  end-page: 364
  ident: bib0125
  article-title: Electrospray mass spectrometry of phospholipids
  publication-title: Mass Spectrom. Rev.
– volume: 63
  start-page: 395
  year: 2001
  end-page: 401
  ident: bib0315
  article-title: Role of spermine in amyloid β-peptide-associated free radical-induced neurotoxicity
  publication-title: J. Neurosci. Res.
– volume: 104
  start-page: 37
  year: 2014
  end-page: 47
  ident: bib0165
  article-title: Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease
  publication-title: J. Proteomics
– volume: 44
  start-page: 1268
  year: 2003
  end-page: 1278
  ident: bib0285
  article-title: Cholesterol sulfate in human physiology: what's it all about
  publication-title: J. Lipid Res.
– volume: 29
  start-page: 1423
  year: 2008
  end-page: 1433
  ident: bib0025
  article-title: Age related changes in brain metabolites observed by
  publication-title: Neurobiol. Aging
– volume: 25
  start-page: 52
  year: 2012
  end-page: 58
  ident: bib0045
  article-title: Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by
  publication-title: NMR Biomed.
– volume: 10
  start-page: 390
  year: 2013
  end-page: 405
  ident: bib0235
  article-title: Age-related mitochondrial alterations without neuronal loss in the hippocampus of a transgenic model of Alzheimer's disease
  publication-title: Curr. Alzheimer Res.
– volume: 7
  start-page: e32737
  year: 2012
  ident: bib0085
  article-title: Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease
  publication-title: PLoS ONE
– volume: 10
  start-page: 744
  year: 2014
  end-page: 753
  ident: bib0215
  article-title: Metabolic signatures of human Alzheimer's disease (AD):
  publication-title: Metabolomics
– volume: 7
  start-page: e31501
  year: 2012
  ident: bib0265
  article-title: Metabolite profiling of Alzheimer's disease cerebrospinal fluid
  publication-title: PLoS ONE
– volume: 525
  start-page: 1
  year: 2004
  end-page: 10
  ident: bib0130
  article-title: Structural identification of human blood phospholipids using liquid chromatography/quadrupole-linear ion trap mass spectrometry
  publication-title: Anal. Chim. Acta
– volume: 71
  start-page: 2034
  year: 1998
  end-page: 2040
  ident: bib0275
  article-title: Increased nuclear DNA oxidation in the brain in Alzheimer's disease
  publication-title: J. Neurochem.
– volume: 9
  start-page: 974
  year: 2013
  end-page: 983
  ident: bib0050
  article-title: H NMR metabolomics investigation of an Alzheimer's disease (AD) mouse model pinpoints important biochemical disturbances in brain and plasma
  publication-title: Metabolomics
– volume: 131
  start-page: 1075
  year: 2006
  end-page: 1078
  ident: bib0115
  article-title: A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis
  publication-title: Analyst
– volume: 9
  start-page: S4
  year: 2013
  end-page: S29
  ident: bib0095
  article-title: Flow infusion electrospray ionisation mass spectrometry for high throughput, non-targeted metabolite fingerprinting: a review
  publication-title: Metabolomics
– volume: 14
  start-page: 213
  year: 1991
  end-page: 226
  ident: bib0340
  article-title: Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E
  publication-title: Mol. Chem. Neuropathol.
– volume: 32
  start-page: 2757
  year: 2011
  end-page: 2764
  ident: bib0310
  article-title: Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease
  publication-title: Electrophoresis
– volume: 66
  start-page: 829
  year: 2012
  end-page: 835
  ident: bib0160
  article-title: Metabolomic approach to Alzheimer's disease diagnosis based on mass spectrometry
  publication-title: Chem. Papers
– volume: 71
  start-page: 868
  year: 2012
  end-page: 881
  ident: bib0280
  article-title: Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease
  publication-title: J. Neuropathol. Exp. Neurol.
– volume: 203
  start-page: 29
  year: 1996
  end-page: 32
  ident: bib0300
  article-title: Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients
  publication-title: Neurosci. Lett.
– volume: 68
  start-page: 2061
  year: 1997
  end-page: 2069
  ident: bib0270
  article-title: An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease
  publication-title: J. Neurochem.
– volume: 98
  start-page: 321
  year: 2014
  end-page: 326
  ident: bib0170
  article-title: Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry
  publication-title: J. Pharm. Biomed. Anal.
– volume: 199
  start-page: 231
  year: 2005
  end-page: 233
  ident: bib0345
  article-title: Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease
  publication-title: Neurosci. Lett.
– volume: 51
  start-page: 660
  year: 2010
  end-page: 671
  ident: bib0210
  article-title: Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain
  publication-title: J. Lipid Res.
– volume: 1292
  start-page: 93
  year: 2009
  end-page: 99
  ident: bib0015
  article-title: Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease
  publication-title: Brain Res.
– volume: 14
  start-page: 1
  year: 2012
  end-page: 14
  ident: bib0250
  article-title: Roles of AMP-activated protein kinase in Alzheimer's disease
  publication-title: Neuromol. Med.
– volume: 50
  start-page: 313
  year: 2011
  ident: 10.1016/j.jpba.2014.10.009_bib0185
  article-title: Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology
  publication-title: Prog. Lipid Res.
  doi: 10.1016/j.plipres.2011.06.001
– volume: 7
  start-page: e32737
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0085
  article-title: Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0032737
– volume: 50
  start-page: 21
  year: 2013
  ident: 10.1016/j.jpba.2014.10.009_bib0295
  article-title: Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2012.09.003
– volume: 21
  start-page: 1013
  year: 2010
  ident: 10.1016/j.jpba.2014.10.009_bib0325
  article-title: Is the urea cycle involved in Alzheimer's disease
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-2010-100630
– volume: 2011
  start-page: 517160
  year: 2011
  ident: 10.1016/j.jpba.2014.10.009_bib0010
  article-title: Utilization of APPswe/PS1dE9 transgenic mice in research of Alzheimer's disease: focus on gene therapy and cell-based therapy applications
  publication-title: Int. J. Alzheimers Dis.
  doi: 10.4061/2011/517160
– volume: 13
  start-page: 440
  year: 2003
  ident: 10.1016/j.jpba.2014.10.009_bib0260
  article-title: A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer's disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation
  publication-title: Brain Pathol.
  doi: 10.1111/j.1750-3639.2003.tb00475.x
– volume: 131
  start-page: 1075
  year: 2006
  ident: 10.1016/j.jpba.2014.10.009_bib0115
  article-title: A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis
  publication-title: Analyst
  doi: 10.1039/b604498k
– volume: 211
  start-page: 125
  year: 2010
  ident: 10.1016/j.jpba.2014.10.009_bib0060
  article-title: Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP–PS1 by 1H HR-MAS
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2010.03.026
– volume: 44
  start-page: 1268
  year: 2003
  ident: 10.1016/j.jpba.2014.10.009_bib0285
  article-title: Cholesterol sulfate in human physiology: what's it all about
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.R300005-JLR200
– volume: 1012
  start-page: 60
  year: 2004
  ident: 10.1016/j.jpba.2014.10.009_bib0040
  article-title: Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2004.02.079
– volume: 7
  start-page: e31501
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0265
  article-title: Metabolite profiling of Alzheimer's disease cerebrospinal fluid
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0031501
– volume: 14
  start-page: 54
  year: 2008
  ident: 10.1016/j.jpba.2014.10.009_bib0290
  article-title: Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease
  publication-title: Trends Mol. Med.
  doi: 10.1016/j.molmed.2007.12.001
– volume: 19
  start-page: 385
  year: 1998
  ident: 10.1016/j.jpba.2014.10.009_bib0245
  article-title: Elevated adenosine monophosphate deaminase activity in Alzheimer's disease brain
  publication-title: Neurobiol. Aging
  doi: 10.1016/S0197-4580(98)00083-9
– volume: 14
  start-page: 213
  year: 1991
  ident: 10.1016/j.jpba.2014.10.009_bib0340
  article-title: Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E
  publication-title: Mol. Chem. Neuropathol.
  doi: 10.1007/BF03159937
– volume: 68
  start-page: 2061
  year: 1997
  ident: 10.1016/j.jpba.2014.10.009_bib0270
  article-title: An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1997.68052061.x
– volume: 287
  start-page: 2678
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0200
  article-title: Comparative lipidomic analysis of mouse and human brain with Alzheimer disease
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.274142
– volume: 7
  start-page: 142
  year: 2006
  ident: 10.1016/j.jpba.2014.10.009_bib0120
  article-title: Centering, scaling, and transformations: improving the biological information content of metabolomics data
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-7-142
– volume: 14
  start-page: 1
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0250
  article-title: Roles of AMP-activated protein kinase in Alzheimer's disease
  publication-title: Neuromol. Med.
  doi: 10.1007/s12017-012-8173-2
– volume: 11
  start-page: 5903
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0080
  article-title: Metabonomic profiling of TASTPM transgenic alzheimer's disease mouse model
  publication-title: J. Proteome Res.
  doi: 10.1021/pr300666p
– volume: 39
  start-page: 121
  year: 2014
  ident: 10.1016/j.jpba.2014.10.009_bib0065
  article-title: 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-130023
– volume: 9
  start-page: S4
  year: 2013
  ident: 10.1016/j.jpba.2014.10.009_bib0095
  article-title: Flow infusion electrospray ionisation mass spectrometry for high throughput, non-targeted metabolite fingerprinting: a review
  publication-title: Metabolomics
  doi: 10.1007/s11306-012-0449-x
– volume: 39
  start-page: 841
  year: 2014
  ident: 10.1016/j.jpba.2014.10.009_bib0090
  article-title: Age-related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: a spontaneous Alzheimer's disease mouse model
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-131463
– volume: 525
  start-page: 1
  year: 2004
  ident: 10.1016/j.jpba.2014.10.009_bib0130
  article-title: Structural identification of human blood phospholipids using liquid chromatography/quadrupole-linear ion trap mass spectrometry
  publication-title: Anal. Chim. Acta
  doi: 10.1016/j.aca.2004.07.065
– volume: 984
  start-page: 203
  year: 2003
  ident: 10.1016/j.jpba.2014.10.009_bib0135
  article-title: Determination of carnitine and acylcarnitines in urine by high-performance liquid chromatography–electrospray ionization ion trap tandem mass spectrometry
  publication-title: J. Chromatogr. A
  doi: 10.1016/S0021-9673(02)01838-1
– volume: 203
  start-page: 29
  year: 1996
  ident: 10.1016/j.jpba.2014.10.009_bib0300
  article-title: Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients
  publication-title: Neurosci. Lett.
  doi: 10.1016/0304-3940(95)12256-7
– volume: 88
  start-page: 3155
  year: 2010
  ident: 10.1016/j.jpba.2014.10.009_bib0030
  article-title: Reduction of hippocampal N-acetyl aspartate level in aged APPSwe/PS1dE9 transgenic mice is associated with degeneration of CA3 pyramidal neurons
  publication-title: J. Neurosci. Res.
  doi: 10.1002/jnr.22479
– volume: 104
  start-page: 37
  year: 2014
  ident: 10.1016/j.jpba.2014.10.009_bib0165
  article-title: Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease
  publication-title: J. Proteomics
  doi: 10.1016/j.jprot.2014.01.014
– volume: 18
  start-page: 211
  year: 2008
  ident: 10.1016/j.jpba.2014.10.009_bib0255
  article-title: Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease
  publication-title: Brain Pathol.
  doi: 10.1111/j.1750-3639.2007.00112.x
– volume: 66
  start-page: 829
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0160
  article-title: Metabolomic approach to Alzheimer's disease diagnosis based on mass spectrometry
  publication-title: Chem. Papers
  doi: 10.2478/s11696-012-0184-9
– volume: 1800
  start-page: 1121
  year: 2010
  ident: 10.1016/j.jpba.2014.10.009_bib0225
  article-title: Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbagen.2010.06.002
– volume: 13
  start-page: 159
  year: 2004
  ident: 10.1016/j.jpba.2014.10.009_bib0110
  article-title: Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific g secretase
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddh019
– volume: 88
  start-page: 3
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0005
  article-title: Mouse models of Alzheimer's disease
  publication-title: Brain Res. Bull.
  doi: 10.1016/j.brainresbull.2011.11.017
– volume: 26
  start-page: 51
  year: 2007
  ident: 10.1016/j.jpba.2014.10.009_bib0070
  article-title: Mass spectrometry-based metabolomics
  publication-title: Mass Spectrom. Rev.
  doi: 10.1002/mas.20108
– volume: 34
  start-page: 102
  year: 2009
  ident: 10.1016/j.jpba.2014.10.009_bib0190
  article-title: Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-008-9673-1
– volume: 118
  start-page: 45
  year: 2014
  ident: 10.1016/j.jpba.2014.10.009_bib0105
  article-title: Ultra high resolution mass spectrometry-based metabolic characterization reveals cerebellum as a disturbed region in two animal models
  publication-title: Talanta
  doi: 10.1016/j.talanta.2013.09.019
– volume: 20
  start-page: 705
  year: 1995
  ident: 10.1016/j.jpba.2014.10.009_bib0220
  article-title: Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain
  publication-title: Neurochem. Res.
  doi: 10.1007/BF01705539
– volume: 77
  start-page: 1168
  year: 2001
  ident: 10.1016/j.jpba.2014.10.009_bib0195
  article-title: McKeel Jr DW. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.2001.00332.x
– volume: 32
  start-page: 2757
  year: 2011
  ident: 10.1016/j.jpba.2014.10.009_bib0310
  article-title: Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease
  publication-title: Electrophoresis
  doi: 10.1002/elps.201100139
– volume: 29
  start-page: 1961
  year: 2004
  ident: 10.1016/j.jpba.2014.10.009_bib0175
  article-title: Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-004-6871-3
– volume: 26
  start-page: 2342
  year: 2010
  ident: 10.1016/j.jpba.2014.10.009_bib0140
  article-title: MetPA: a web-based metabolomics tool for pathway analysis and visualization
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq418
– volume: 272
  start-page: 4874
  year: 2005
  ident: 10.1016/j.jpba.2014.10.009_bib0230
  article-title: 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease
  publication-title: FEBS J.
  doi: 10.1111/j.1742-4658.2005.04911.x
– volume: 4
  start-page: 189
  year: 2004
  ident: 10.1016/j.jpba.2014.10.009_bib0020
  article-title: Metabonomics and its role in drug development and disease diagnosis
  publication-title: Expert Rev. Mol. Diagn.
  doi: 10.1586/14737159.4.2.189
– volume: 9
  start-page: 974
  year: 2013
  ident: 10.1016/j.jpba.2014.10.009_bib0050
  article-title: 1H NMR metabolomics investigation of an Alzheimer's disease (AD) mouse model pinpoints important biochemical disturbances in brain and plasma
  publication-title: Metabolomics
  doi: 10.1007/s11306-013-0516-y
– volume: 1292
  start-page: 93
  year: 2009
  ident: 10.1016/j.jpba.2014.10.009_bib0015
  article-title: Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2009.07.066
– volume: 56
  start-page: 937
  year: 2010
  ident: 10.1016/j.jpba.2014.10.009_bib0055
  article-title: A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2010.04.001
– volume: 51
  start-page: 660
  year: 2010
  ident: 10.1016/j.jpba.2014.10.009_bib0210
  article-title: Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.D001750
– volume: 29
  start-page: 1423
  year: 2008
  ident: 10.1016/j.jpba.2014.10.009_bib0025
  article-title: Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2007.03.002
– volume: 71
  start-page: 868
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0280
  article-title: Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/NEN.0b013e31826be03c
– volume: 14
  start-page: 21021
  year: 2013
  ident: 10.1016/j.jpba.2014.10.009_bib0335
  article-title: Impaired glutathione synthesis in neurodegeneration
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms141021021
– volume: 235
  start-page: 1
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0035
  article-title: Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2012.07.016
– volume: 1
  start-page: 617
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0075
  article-title: A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2012.05.001
– volume: 405
  start-page: 5105
  year: 2013
  ident: 10.1016/j.jpba.2014.10.009_bib0100
  article-title: Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer's disease in CRND8 mice
  publication-title: Anal. Bioanal. Chem.
  doi: 10.1007/s00216-013-6825-1
– volume: 122
  start-page: 271
  year: 2011
  ident: 10.1016/j.jpba.2014.10.009_bib0205
  article-title: Peroxisomal alterations in Alzheimer's disease
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-011-0836-9
– volume: 21
  start-page: 331
  year: 1987
  ident: 10.1016/j.jpba.2014.10.009_bib0330
  article-title: Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.410210403
– volume: 135
  start-page: 2970
  year: 2010
  ident: 10.1016/j.jpba.2014.10.009_bib0145
  article-title: Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer
  publication-title: Analyst
  doi: 10.1039/c0an00265h
– volume: 309
  start-page: 200
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0155
  article-title: Diagnosis of lung cancer based on direct-infusion electrospray mass spectrometry of blood plasma metabolites
  publication-title: Int. J. Mass Spectrom.
  doi: 10.1016/j.ijms.2011.10.002
– volume: 63
  start-page: 395
  year: 2001
  ident: 10.1016/j.jpba.2014.10.009_bib0315
  article-title: Role of spermine in amyloid β-peptide-associated free radical-induced neurotoxicity
  publication-title: J. Neurosci. Res.
  doi: 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q
– volume: 6
  start-page: 156
  year: 2010
  ident: 10.1016/j.jpba.2014.10.009_bib0150
  article-title: Metabolite profiling of blood plasma of patients with prostate cancer
  publication-title: Metabolomics
  doi: 10.1007/s11306-009-0187-x
– volume: 10
  start-page: 744
  year: 2014
  ident: 10.1016/j.jpba.2014.10.009_bib0215
  article-title: Metabolic signatures of human Alzheimer's disease (AD): 1H NMR analysis of the polar metabolome of post-mortem brain tissue
  publication-title: Metabolomics
  doi: 10.1007/s11306-013-0610-1
– volume: 25
  start-page: 52
  year: 2012
  ident: 10.1016/j.jpba.2014.10.009_bib0045
  article-title: Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by 1H MRS in vitro
  publication-title: NMR Biomed.
  doi: 10.1002/nbm.1712
– volume: 71
  start-page: 2034
  year: 1998
  ident: 10.1016/j.jpba.2014.10.009_bib0275
  article-title: Increased nuclear DNA oxidation in the brain in Alzheimer's disease
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1998.71052034.x
– volume: 3
  start-page: 2364
  year: 2013
  ident: 10.1016/j.jpba.2014.10.009_bib0320
  article-title: Metabolic profiling of Alzheimer's disease brains
  publication-title: Sci. Rep.
  doi: 10.1038/srep02364
– volume: 98
  start-page: 321
  year: 2014
  ident: 10.1016/j.jpba.2014.10.009_bib0170
  article-title: Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2014.05.023
– volume: 22
  start-page: 332
  year: 2003
  ident: 10.1016/j.jpba.2014.10.009_bib0125
  article-title: Electrospray mass spectrometry of phospholipids
  publication-title: Mass Spectrom. Rev.
  doi: 10.1002/mas.10061
– volume: 32
  start-page: 213
  year: 2007
  ident: 10.1016/j.jpba.2014.10.009_bib0305
  article-title: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects
  publication-title: Amino Acids
  doi: 10.1007/s00726-006-0409-8
– volume: 25
  start-page: 1299
  year: 2004
  ident: 10.1016/j.jpba.2014.10.009_bib0180
  article-title: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2004.02.016
– volume: 10
  start-page: 390
  year: 2013
  ident: 10.1016/j.jpba.2014.10.009_bib0235
  article-title: Age-related mitochondrial alterations without neuronal loss in the hippocampus of a transgenic model of Alzheimer's disease
  publication-title: Curr. Alzheimer Res.
  doi: 10.2174/1567205011310040005
– volume: 199
  start-page: 231
  year: 2005
  ident: 10.1016/j.jpba.2014.10.009_bib0345
  article-title: Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease
  publication-title: Neurosci. Lett.
  doi: 10.1016/0304-3940(95)12058-C
SSID ssj0005194
Score 2.4021697
Snippet •Direct infusion mass spectrometry allows a comprehensive brain metabolomic analysis.•The APP/PS1 mice exhibited an abnormal neurochemical profile compared to...
The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 425
SubjectTerms Alzheimer Disease - genetics
Alzheimer Disease - metabolism
Alzheimer's disease
Amyloid beta-Protein Precursor - genetics
Animals
APP/PS1 mice
Brain - metabolism
Brain regions
Direct infusion mass spectrometry
Disease Models, Animal
Female
Male
Mass Spectrometry - methods
Metabolomics
Metabolomics - methods
Mice
Mice, Inbred C57BL
Mice, Transgenic
Presenilin-1 - genetics
Title Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry
URI https://dx.doi.org/10.1016/j.jpba.2014.10.009
https://www.ncbi.nlm.nih.gov/pubmed/25459942
https://www.proquest.com/docview/1652437689
https://www.proquest.com/docview/1660388210
Volume 102
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUQXHqpWujHUoqmUkUPJWy8sZ3kuEKgbStQJEDiFtmxrS5adle72cNy6F_oX-6Mk0B7YA89xrIdKzPxvLFn3jD2OaksF8bqqJKpRgcltZHmNom8UT5TXMdaUYLzxaUa3Yjvt_J2i512uTAUVtnu_c2eHnbrtqXffs3-fDzuX6Fy8pQQgyASk5BRLkRKWn7y668wDx6KIVLniHq3iTNNjNfd3BD3EBcnIcIrf844PQc-gxE6f8VetugRhs0CX7MtN91lR0VDP70-huunbKrlMRxB8URMvd5jvy9cjTKfUCIy4HaBLiwaLph5oPIMBMnBUMUICFfozVEe4CNiRBgWRb-44lCTbUOlwxlCER0aPZw8_HTje7f4soT2wgfMGpovixP4FR3JwT3idAiZnUSRUC_Wb9jN-dn16ShqCzJEFTpGdZS5zJgBYjrjvZYyNbF0QhGDjdU5z7W3Rg2qFFFV4mPtufHKiUQPXBL7KkXg8JZtT2dT956BVcbGGdXNkoZu-HMr8so6GmgdvqDHeCeJsmrZyqloxqTswtLuSpJeSdKjNpRej319HDNvuDo29padgMt_NK5EY7Jx3KdOG0r8Fel-RU_dbLUsuZJE76iyjX0U8e-go91j7xpVelwr-uoyz8Vg_z9X9oG9wCcZDojkAduuFyv3ESFTbQ7DP3HIdobffowu_wCVSxge
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBaK9LBdhr2Xrds4YOgOqxcrtmT7GBQr0rUJDDQFehMkS8JSpEmQOIf0T-wvj_SjwQ7NYcc4oi2YtPhRIj8y9jUqLI-N1UEhEo0BSmIDzW0UeCN9KrkOtaQC59FYDq_jXzfi5oCdtrUwlFbZrP31ml6t1s2VXvM2e8vptHeFxskTQgwxkZhQRfkhsVOJDjscnF8Mx7tMD171Q6TxAQk0tTN1mtft0hD9EI9_VEle2WP-6TH8Wfmhs-fsWQMgYVDP8QU7cPOX7DivGai3JzDZFVStT-AY8h039fYV-zNyJap9RrXIgCsGRrHou2DhgTo0ECoHQ00joDpFr3fzAH8iTIRBnvfyKw4luTe0O7xD1UeHpAez-99ueudW39bQnPmA2UL9cvEGfkO7cnCHUB2q4k5iSShX29fs-uzn5HQYND0ZggJjozJIXWpMH2Gd8V4LkZhQuFgSiY3VGc-0t0b2iwSBVeRD7bnx0sWR7rso9EWC2OEN68wXc_eOgZXGhim1zhKGDvkzG2eFdSRoHT6gy3irCVU0hOXUN2Om2sy0W0XaU6Q9uoba67LvDzLLmq5j72jRKlj9Y3QK_cleuS-tNSj8GumIRc_dYrNWXApieJTp3jGSKHgw1u6yt7UpPcwVw3WRZXH__X_O7DN7MpyMLtXl-fjiA3uK_4hqv0gcsU652riPiKBK86n5Qv4CGqcazw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolomic+screening+of+regional+brain+alterations+in+the+APP%2FPS1+transgenic+model+of+Alzheimer%27s+disease+by+direct+infusion+mass+spectrometry&rft.jtitle=Journal+of+pharmaceutical+and+biomedical+analysis&rft.au=Gonz%C3%A1lez-Dom%C3%ADnguez%2C+Ra%C3%BAl&rft.au=Garc%C3%ADa-Barrera%2C+Tamara&rft.au=Vitorica%2C+Javier&rft.au=G%C3%B3mez-Ariza%2C+Jos%C3%A9+Luis&rft.date=2015-01-05&rft.pub=Elsevier+B.V&rft.issn=0731-7085&rft.eissn=1873-264X&rft.volume=102&rft.spage=425&rft.epage=435&rft_id=info:doi/10.1016%2Fj.jpba.2014.10.009&rft.externalDocID=S0731708514005007
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0731-7085&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0731-7085&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0731-7085&client=summon